Geriatric Anxiety Scale (GAS-GV-10)

Introduction

The Geriatric Anxiety Scale (GAS-GV-10) is a specialized psychometric instrument developed to assess the presence and severity of anxiety symptoms in older adults. The scale was specifically designed to address the unique clinical presentation of anxiety in later life, recognizing that anxiety symptoms in elderly individuals often differ from those observed in younger adults. Older adults frequently experience anxiety through a combination of cognitive concerns, emotional distress, and physical symptoms that may overlap with age-related medical conditions. The GAS-GV-10 provides healthcare professionals with a reliable, standardized, and age-appropriate method for identifying anxiety symptoms and supporting evidence-based clinical decision-making. It is widely used in geriatric psychiatry, clinical psychology, primary healthcare, gerontology, and aging research.

Anxiety disorders remain among the most common yet underrecognized mental health conditions in older adults. Because anxiety symptoms are often attributed to normal aging or chronic physical illness, many elderly individuals remain untreated despite experiencing clinically significant psychological distress. Early assessment is therefore essential for improving diagnosis, treatment planning, quality of life, and overall functional independence. The GAS-GV-10 was developed to facilitate this process by providing a concise and clinically meaningful assessment of anxiety specifically tailored to older populations.

What is the GAS-GV-10?

The Geriatric Anxiety Scale (GAS-GV-10) is an anxiety assessment questionnaire specifically designed for older adults. Its purpose is to systematically evaluate the frequency and severity of anxiety symptoms while taking into account the psychological, emotional, and physical changes associated with aging. The questionnaire examines cognitive, affective, and somatic manifestations of anxiety, providing a comprehensive assessment of psychological well-being in later life.

The instrument can be used both as an initial screening tool and as an outcome measure for monitoring symptom progression during psychological, pharmacological, or psychosocial interventions. Its brief format makes it particularly suitable for use in hospitals, primary healthcare services, geriatric clinics, long-term care facilities, community health programs, and scientific research involving older adults.

Theoretical Background

Anxiety disorders are among the most prevalent psychiatric conditions affecting older adults and frequently coexist with depression, chronic medical illnesses, cognitive impairment, and functional disability. Identifying anxiety in later life can be particularly challenging because elderly individuals often express psychological distress through physical symptoms such as muscle tension, fatigue, insomnia, palpitations, gastrointestinal discomfort, or general health concerns rather than through overt emotional complaints.

The GAS-GV-10 is based on the contemporary understanding that assessing anxiety in older adults requires age-specific instruments capable of distinguishing anxiety symptoms from the normal physiological changes associated with aging and from symptoms caused by chronic medical conditions. By emphasizing both psychological and somatic aspects of anxiety, the instrument provides a more accurate and clinically meaningful assessment of anxiety among elderly populations.

This comprehensive approach supports early identification of anxiety disorders, facilitates individualized treatment planning, and contributes to improved mental health care for older adults.

Development of the Instrument

The Geriatric Anxiety Scale (GAS) was developed to provide a specialized instrument for assessing anxiety among older adults, addressing limitations associated with general anxiety measures that were not specifically designed for geriatric populations. The development and validation process emphasized psychometric reliability, construct validity, internal consistency, and criterion validity, with comparisons made against other internationally recognized anxiety assessment instruments.

Today, the GAS-GV-10 is widely implemented in geriatric psychiatry clinics, primary healthcare settings, hospitals, long-term care facilities, community mental health services, and aging research programs. Owing to its brevity, ease of administration, and strong psychometric foundation, the instrument has become an important tool for screening anxiety, evaluating treatment outcomes, monitoring symptom progression, and supporting research focused on the mental health and psychological well-being of older adults.